Glen Eagle Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Hold
64
﹤0.01% 624
2025
Q4
$13.2K Buy
64
+5
+8% +$941 ﹤0.01% 646
2025
Q3
$9.26K Buy
59
+29
+97% +$4.48K ﹤0.01% 704
2025
Q2
$5.04K Hold
30
﹤0.01% 726
2025
Q1
$4.13K Hold
30
﹤0.01% 754
2024
Q4
$3.55K Hold
30
﹤0.01% 794
2024
Q3
$3.32K Hold
30
﹤0.01% 837
2024
Q2
$2.95K Hold
30
﹤0.01% 841
2024
Q1
$3.36K Buy
+30
New +$3.24K ﹤0.01% 839
2018
Q2
Sell
-195
Closed -$12.2K 692
2018
Q1
$12.2K Buy
195
+17
+10% +$1.17K 0.01% 414
2017
Q4
$10.9K Hold
178
0.01% 417
2017
Q3
$11.9K Sell
178
-181
-50% -$12.8K 0.01% 410
2017
Q2
$28K Buy
359
+178
+98% +$13.4K 0.02% 265
2017
Q1
$14.8K Buy
181
+175
+2,917% +$13.8K 0.01% 323
2016
Q4
$432 Buy
+6
New +$434 ﹤0.01% 531

Other funds holding CAH

Glen Eagle Advisors's CAH Position: Q1 2026 in Review

Glen Eagle Advisors held its Cardinal Health (CAH) position steady in Q1 2026 at 64 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #624.

Glen Eagle Advisors first reported a position in CAH in Q4 2016 and has held it in 15 quarters since. The position peaked at $28K in Q2 2017. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Glen Eagle Advisors held 64 shares of Cardinal Health worth $13.6K as of Q1 2026.
  • Glen Eagle Advisors left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #624 holding.
  • Glen Eagle Advisors first reported a position in Cardinal Health in Q4 2016 and has held it in 15 quarters since.
  • Glen Eagle Advisors's Cardinal Health position peaked at $28K in Q2 2017.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.